ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 95466 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 95466; 2) Community: the network communities that were significantly associated with the response to NSC 95466; 3) Molecule: the relationships between components within communities and NSC 95466; 4) MDR: the compounds that were significantly associated with the NSC 95466.

NSC Compound Enrichment Correlation
NSC 636476 cis-Difluorobis[1-(phenyl-2,4,6-trimethyl)butane-1,3- dionato]titanium(IV) 0.0119221520283057 0.29608788
NSC 671139 Null 0.0119221520283057 0.11275285
NSC 689547 Null 0.0119221520283057 -0.26856617
NSC 729812 6-(3-Chloropropyl)-5,6-dihydro-8,9-methylenedioxy-5,11-dioxo -3-nitro-11H-indeno[1,2-c]isoquinoline 0.0119221520283057 0.44219453
NSC 747973 Ixabepilone 0.0119221520283057 0.236775
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0122129861493296 0.34674283
NSC 166199 Phosphinic amide, P,P-bis(1-aziridinyl)-N-tricyclo[3.3.1.1(3.7)]dec-1-yl- (9CI) 0.0122129861493296 0.60609239
NSC 295499 Camptothecin Derivative 0.0122129861493296 0.6995962
NSC 354051 LISCUNDITRIN 0.0122129861493296 0.19375321
NSC 48526 Null 0.0122129861493296 0.091332706
Total:60  Current:15    [First] [Prev] [Next] [Last]